Tom Brady, the legendary NFL quarterback, has sparked conversations across the worlds of science, ethics, and animal companionship with the news that his newest dog, Junie, is not just a beloved new pet—but a genetic clone of his late dog Lua.
When Brady first introduced Junie, fans immediately commented on the dog’s uncanny resemblance to Lua, a Pit Bull mix who had been part of the family for many years. As it turns out, there was a good reason for the likeness. Junie is not simply similar—she is Lua’s exact DNA replica.
This extraordinary move was made possible by advanced cloning technology developed by Colossal Biosciences, a Dallas-based biotechnology firm Brady has invested in. Using a non-invasive blood draw taken from Lua prior to her death in December 2023, scientists were able to extract viable DNA and bring forth Junie—offering Brady’s family what he described as “a second chance.”
In a statement, Brady expressed the emotional depth of the decision: “I love my animals. They mean the world to me and my family. A few years ago, I worked with Colossal and leveraged their non-invasive cloning technology through a simple blood draw of our family’s elderly dog before she passed.”
This scientific feat was made even more notable with Colossal’s recent acquisition of Viagen Pets and Equine, the leading pet cloning company renowned for replicating animals for celebrities such as Barbra Streisand and Paris Hilton. Viagen holds exclusive rights to cloning technology derived from the iconic Roslin Institute in Scotland—the same institute responsible for cloning Dolly the sheep in the 1990s.
Lua played a vital role in the Brady household. Adopted by Brady and his former wife, supermodel Gisele Bündchen, Lua was more than just a pet; she was a companion, a protector, and a presence in countless family memories. Lua even featured in a 2014 Ugg Australia commercial with Brady and frequently appeared on their social media. Her passing was deeply mourned by both Brady and Bündchen, who shared heartfelt tributes to the dog who had been part of their children’s upbringing.
Bündchen wrote on Instagram: “Our little Lulu, our guardian angel, is gone to heaven. She will forever live in our hearts. We already miss her so much.”
Brady echoed the sentiment, posting: “We love you Lua, RIP… forever in our hearts.” The emotional response from the family is what led to exploring the cloning process as a means of grieving while preserving the connection they had developed with Lua.
While many see cloning as a miraculous avenue for pet owners to reconnect with their lost animals, others are raising questions. The ethical implications of cloning—ranging from animal welfare to the moral concerns over replication of life—remain hotly debated. For some, it feels like science crossing an emotional boundary. For others, it’s an example of how deeply human-animal bonds can motivate technological innovation.
At the heart of this discussion are key questions:
- Does cloning provide emotional closure—or does it complicate the grief process by blurring the line between memory and replication?
- What are the implications for animal welfare, especially regarding surrogate mothers used in the cloning process?
- Could such technology be democratized, or will it remain a luxury for the wealthy?
Colossal Biosciences, already a major player in the space of de-extinction with projects aimed at reviving the woolly mammoth and other extinct species, sees pet cloning as another step toward harnessing genetic science for deeply personal—and potentially conservation-worthy—purposes.
For Brady’s family, Junie isn’t just a scientific achievement; she’s a continuation of a once-in-a-lifetime bond. Her presence is both a comfort and a tribute to the loyalty and love of Lua, echoing in every glance, bark, and gentle nudge.
Facebook Comments